Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
PRospective Multiple Myeloma Impact Study
ClinicalTrials.gov study NCT02911571. IPD Sharing: NO. Countries: 1. Publications: 0.
Nivolumab in Multiple Myeloma Patients After Idecabtagene Vicleucel
ClinicalTrials.gov study NCT06523621. IPD Sharing: NO. Countries: 1. Publications: 0.
FR901228 in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00066638. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bortezomib, Melphalan, and Total-Body Irradiation Before Stem Cell Transplant in Treating Patients With Multiple Myeloma
ClinicalTrials.gov study NCT01936090. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Iberdomide, Daratumumab, Bortezomib, and Dexamethasone for Treatment of Newly Diagnosed Multiple Myeloma, IDEAL Study
ClinicalTrials.gov study NCT05392946. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Daratumumab, Carfilzomib, Lenalidomide and Low Dose Dexamethasone (DKRd) in Newly Diagnosed, Multiple Myeloma
ClinicalTrials.gov study NCT03500445. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Comparison of 25mg Versus 5 mg Lenalidomide as Maintenance Therapy in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00891384. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Mass Accumulation Rate (MAR) as a Predictive Biomarker in Multiple Myeloma
ClinicalTrials.gov study NCT03777410. IPD Sharing: NO. Countries: 1. Publications: 0.
A Multicenter In-class Transition Study of Ixazomib Combined With Pomalidomide and Dexamethasone or With Lenalidomide and Dexamethasone in Adults With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05183139. IPD Sharing: YES. Countries: 0. Publications: 0.
A Pharmacokinetic Study of Bortezomib in Taiwanese Participants With Multiple Myeloma
ClinicalTrials.gov study NCT02268890. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vorinostat and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00310024. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Immunomonitoring and Multiple Myeloma: Impact of Lenalidomide on Immune Checkpoint Expression
ClinicalTrials.gov study NCT04872023. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of KQ-2003 CAR-T Cell Therapy for Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06223646. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparison of Geriatric Screening Methods in Newly Diagnosed Multiple Myeloma Patients
ClinicalTrials.gov study NCT02918695. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of YKST02 in Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06574568. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pegfilgrastim (Neulasta) for Stem Cell Mobilization in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00067639. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Dose-Escalation Study of Onc201 Administered Every One or Three Weeks in Advanced Solid Tumors and Multiple Myeloma
ClinicalTrials.gov study NCT02609230. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of Daratumumab in Combination With Ixazomib and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03746652. IPD Sharing: NO. Countries: 1. Publications: 0.
Elotuzumab, Daratumumab, Iberdomide, and Dexamethasone for the Treatment of Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT06785415. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess Adverse Events and Change in Disease Activity of Oral ABBV-453 Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (M
ClinicalTrials.gov study NCT06953960. IPD Sharing: YES. Countries: 8. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.